Bergamot vs Semaglutide

Head-to-head evidence comparison — which supplement is right for you?

Quick answerNo interaction data — ask a pharmacist

Bergamot vs Semaglutide: Semaglutide has the stronger overall evidence (8.5 vs 6.5/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.

Semaglutide Edges Ahead

Semaglutide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.

Bergamot1 win

Semaglutide2 wins

Which is right for you? Take the 60-second quiz Open in the full comparison tool

Bgm6.5

Bergamot

Too few graded studiesHigh safety

Sgl8.5

Semaglutide

Too few graded studiesLimited safety

Evidence

Evidence Score

6.5/10

Studies: 44

Meta-analyses: 3

Level: Moderate

Evidence Score

Best8.5/10

Studies: 455

Meta-analyses: 134

Level: Very Strong

Research findings

Verdict

Too few graded studies

0 of 1 studies with measurable effects showed benefit.

Top outcomes

Cholesterol & lipidsToo few graded studies34
Weight managementToo few graded studies11
Anxiety & stressToo few graded studies6

Verdict

Too few graded studies

Top outcomes

Blood sugar & glycemic controlToo few graded studies197
Weight managementToo few graded studies182
Cardiovascular outcomesToo few graded studies58

Shared outcomes (1)

Outcomes where both Bergamot and Semaglutide have evidence — compare verdict strength side-by-side.

Weight managementToo few graded studies11Too few graded studies182

Dosage & timing

Recommended Dosage:

500-1000mg bergamot polyphenolic fraction (BPF)

Warnings

Not a replacement for statins if medically necessary
Monitor lipid panel to assess effectiveness

Best Time:

With meals, Once or twice daily

Take with food

Best Form:

Bergamot polyphenolic fraction (BPF) — Bergamonte is well-studied

Recommended Dosage:

Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.

Warnings

This is a PRESCRIPTION DRUG, not a dietary supplement — use only under a clinician's care for an approved medical indication.
US FDA labeling includes a boxed warning about thyroid C-cell tumors: semaglutide caused these tumors in rodents; relevance to humans is uncertain. Under the US label it is contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. For treatment in Germany or Austria, consult the current EU product information for the exact medicine’s locally approved indications, contraindications and warnings; discuss any thyroid history with the prescriber.
Risk of acute pancreatitis — discontinue and seek care for severe persistent abdominal pain.
Risk of gallbladder disease (gallstones, cholecystitis), particularly with rapid weight loss.
Gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation) are very common, especially during dose escalation.
Post-marketing reports of ileus (severely slowed gut motility).
May worsen pre-existing diabetic retinopathy, attributed to rapid improvement in glucose control — ensure ophthalmologic monitoring in patients with a history of diabetic retinopathy.
Weight loss includes loss of lean muscle mass — pair with resistance training and adequate protein.
FDA has warned about COMPOUNDED / grey-market semaglutide: risk of dosing errors, impurities, and unapproved salt forms. Use only pharmacy-dispensed product.
Not for cosmetic weight loss without a genuine medical indication.
May increase hypoglycemia risk when combined with insulin or sulfonylureas (dose adjustment needed).

Best Time:

Any time of day

Can take on empty stomach

Best Form:

Subcutaneous once-weekly injection (Ozempic / Wegovy)

Safety

High safetyBest

Drug Interactions:

Statins (moderate)
CYP3A4 substrates (moderate)

Side Effects:

GI upsetHeartburn

Contraindications:

Known allergy or hypersensitivity to Bergamot or related compounds

Limited safety

Drug Interactions:

Other GLP-1 receptor agonists (severe)
Insulin and sulfonylureas (moderate)
Oral medications (general) (moderate)

Side Effects:

NauseaVomiting / diarrhea / constipationGallbladder disease (cholelithiasis / cholecystitis)

Contraindications:

Personal or family history of medullary thyroid carcinoma (MTC) (a contraindication under the US label)
Multiple Endocrine Neoplasia syndrome type 2 (MEN2) (a contraindication under the US label)

Shared goals

Support heart healthBergamot

Bergamot90/100

Semaglutide75/100

Metabolic healthSemaglutide

Bergamot65/100

Semaglutide70/100

What you'll notice

📉 LDL Reductionpositive

4-12 weeks

📊 Triglyceride Reductionpositive

4-12 weeks

📈 HDL Increasepositive

8-12 weeks

🩸 Improved glycemic controlpositive

Weeks to months

⚖️ Substantial weight losspositive

Months (titrated over 16-20 weeks)

❤️ Reduced cardiovascular eventspositive

Months to years

🤢 GI adverse effects (very common)trade-off

Especially during dose escalation

Key studies

A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults

Pharmacological research (2022) · Meta analysis · n=13062

Evidence for bergamot effect was based on relatively small study group and may require further investigations.

Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia

Nutrients (2022) · Rct · n=118

Compared to the placebo, at 6 and 12 weeks, NC did not significantly reduce total cholesterol (p = 0.083), LDL cholesterol (p = 0.150), and triglycerides (p = 0.822).

Effect of bergamot on lipid profile in humans: A systematic review

Critical reviews in food science and nutrition (2020) · Systematic review

Although statins can reduce LDLc by 50-60%, less than 20% of patients with high risk of CVD achieve LDL targets.

All Bergamot studies

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).

N Engl J Med (2021) · Rct · n=1961

Double-blind RCT in 1,961 adults with obesity/overweight WITHOUT diabetes, randomized 2:1 to subcutaneous semaglutide 2.4 mg/week or placebo plus lifestyle for 68 weeks

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT).

N Engl J Med (2023) · Rct · n=17604

Large cardiovascular-outcomes RCT: 17,604 patients with preexisting cardiovascular disease and overweight/obesity but WITHOUT diabetes

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6).

N Engl J Med (2016) · Rct · n=3297

Pre-approval cardiovascular-safety RCT in 3,297 patients with type 2 diabetes at high cardiovascular risk, semaglutide (0.5/1.0 mg/week) vs placebo for 104 weeks

All Semaglutide studies

Frequently asked questions

Is Bergamot better than Semaglutide?

Semaglutide has a higher evidence score (8.5/10 vs 6.5/10) and wins in 2 of 3 categories.

Is Bergamot or Semaglutide better for support heart health?

For support heart health, Bergamot has a higher relevance score (90 vs 75).

Can I take Bergamot and Semaglutide together?

No documented interaction was found in the data searched. This does not establish that this exact combination is safe.

Related comparisons

Bergamot vs Omega-3 Bergamot vs Iodine Bergamot vs Psyllium Husk Bergamot vs Zinc Semaglutide vs Tirzepatide Liraglutide vs Semaglutide

Related guides

Does It Work?

Supplements for Cholesterol

What genuinely lowers LDL/triglycerides — and why "red yeast rice" is a statin in disguise.

Still deciding between Bergamot and Semaglutide?

The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.

Get your personalised pick Bergamot details Semaglutide details

Warnings

This is a PRESCRIPTION DRUG, not a dietary supplement — use only under a clinician's care for an approved medical indication.

US FDA labeling includes a boxed warning about thyroid C-cell tumors: semaglutide caused these tumors in rodents; relevance to humans is uncertain. Under the US label it is contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2. For treatment in Germany or Austria, consult the current EU product information for the exact medicine’s locally approved indications, contraindications and warnings; discuss any thyroid history with the prescriber.

Risk of acute pancreatitis — discontinue and seek care for severe persistent abdominal pain.

Risk of gallbladder disease (gallstones, cholecystitis), particularly with rapid weight loss.

Gastrointestinal adverse effects (nausea, vomiting, diarrhea, constipation) are very common, especially during dose escalation.

Post-marketing reports of ileus (severely slowed gut motility).

May worsen pre-existing diabetic retinopathy, attributed to rapid improvement in glucose control — ensure ophthalmologic monitoring in patients with a history of diabetic retinopathy.

Weight loss includes loss of lean muscle mass — pair with resistance training and adequate protein.

FDA has warned about COMPOUNDED / grey-market semaglutide: risk of dosing errors, impurities, and unapproved salt forms. Use only pharmacy-dispensed product.

Not for cosmetic weight loss without a genuine medical indication.

May increase hypoglycemia risk when combined with insulin or sulfonylureas (dose adjustment needed).

Frequently asked questions

Is Bergamot better than Semaglutide?

Semaglutide has a higher evidence score (8.5/10 vs 6.5/10) and wins in 2 of 3 categories.

Is Bergamot or Semaglutide better for support heart health?

For support heart health, Bergamot has a higher relevance score (90 vs 75).

Can I take Bergamot and Semaglutide together?

No documented interaction was found in the data searched. This does not establish that this exact combination is safe.